Saturday 28 November 2020
Home      All news      Contact us      RSS     
scmp - 1 month ago

Coronavirus: Regeneron’s antiviral cocktail reduces viral load and need for medical care, trial shows

Regeneron Pharmaceuticals said data from a late-stage clinical trial suggest that its antibody cocktail therapy for Covid-19 significantly reduces virus levels and the need for further medical care.Patients getting the therapy were 57 per cent less likely to need medical care within a month of treatment, with 2.8 per cent of those given the antibody and 6.5 per cent of those on placebo seeing a health care worker within 29 days.The Tarrytown, New York-based company has shared the results with…


Latest News
Hashtags:   

Coronavirus

 | 

Regeneron

 | 

antiviral

 | 

cocktail

 | 

reduces

 | 

viral

 | 

medical

 | 

trial

 | 

shows

 | 

Sources